264235-84-9

Upstream product

• 473987-06-3 ethyl 3-(4-piperidinyl)propanoate hydrochloride 
• 123293-78-7 ethyl 3-(4-pyridinyl)-(2E)-propenoate 
• 154775-43-6 3-(1-(tert-butoxycarbonyl)piperidin-4-yl)propanoic acid 
• 301232-45-1 tert-butyl 4-(3-ethoxy-3-oxopropyl)-1-piperidinecarboxylate 
• 25137-01-3 (R)-ethyl nipecotate 
• 872-85-5 pyridine-4-carbaldehyde 
• 169498-18-4 tert-butyl 4-{3-[(3R)-3-(ethoxycarbonyl)-1-piperidinyl]-3-oxopropyl}-1-piperidinecarboxylate 
• 169498-28-6 (3R)-1-{3-[1-(tert-butoxycarbonyl)-4-piperidinyl]propanoyl}-3-piperidinecarboxylic acid 
• 96192-93-7 3-amino-N-<(benzyloxy)carbonyl>-D-alanine methyl ester hydrochloride 

Relevant academic research and scientific papers

Design, synthesis, and structure-activity relationships of potent GPIIb/IIIa antagonists: Discovery of FK419

The discovery of the non-peptide antiplatelet injectable agent FK419 is reported. Based on the β-turn structure of RGD peptide sequences in the α chain of fibrinogen, which binds the glycoprotein IIb/IIIa (GPIIb/IIIa) on the surface of platelets to induce